These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization. Diana M; Young SJ; Groves PM Neuroscience; 1991; 42(2):441-9. PubMed ID: 1680226 [TBL] [Abstract][Full Text] [Related]
10. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen. Girault JA; Spampinato U; Glowinski J; Besson MJ Neuroscience; 1986 Dec; 19(4):1109-17. PubMed ID: 2950336 [TBL] [Abstract][Full Text] [Related]
11. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors. Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763 [TBL] [Abstract][Full Text] [Related]
12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
13. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro. Momiyama T; Todo N; Sasa M Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors. Delgado A; Sierra A; Querejeta E; Valdiosera RF; Aceves J Neuroscience; 2000; 95(4):1043-8. PubMed ID: 10682711 [TBL] [Abstract][Full Text] [Related]
15. Modulation of dopaminergic terminal excitability by D1 selective agents. Diana M; Young SJ; Groves PM Neuropharmacology; 1989 Jan; 28(1):99-101. PubMed ID: 2522599 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of striatal cell subtypes using in vivo intracellular recording in rats: II. Membrane factors underlying paired-pulse response profiles. Onn SP; Berger TW; Grace AA Synapse; 1994 Mar; 16(3):195-210. PubMed ID: 8197582 [TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions. Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317 [TBL] [Abstract][Full Text] [Related]
18. GABAergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo. Brazhnik E; Shah F; Tepper JM J Neurosci; 2008 Oct; 28(41):10386-98. PubMed ID: 18842898 [TBL] [Abstract][Full Text] [Related]
19. Long-term synaptic depression in the striatum: physiological and pharmacological characterization. Calabresi P; Maj R; Pisani A; Mercuri NB; Bernardi G J Neurosci; 1992 Nov; 12(11):4224-33. PubMed ID: 1359031 [TBL] [Abstract][Full Text] [Related]
20. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Hu XT; Brooderson RJ; White FJ Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]